FLNC-related myopathy: a description of 27 patients from 21 unrelated families
This study characterizes the clinical, radiological, and pathological features of a large multicenter cohort of 27 patients with FLNC-related myopathy, confirming that the disease typically presents as an adult-onset proximal myopathy with frequent cardiac involvement and a distinct MRI pattern, despite significant clinical heterogeneity and a lack of clear genotype–phenotype correlation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Muscles are not just bundles of fibers that pull on bones; they are complex, living structures that rely on a precise internal scaffolding to function. Imagine a building where the steel beams and concrete walls are held together by a specific type of industrial glue. If that glue fails, the structure becomes unstable, and the building begins to crumble. In the human body, a protein called filamin C acts as that essential glue for muscle cells. It helps hold the internal framework of the muscle fiber together, ensuring that when a signal comes from the brain to move, the muscle contracts smoothly and powerfully. When the gene that provides instructions for making this protein, known as FLNC, carries a mistake, the scaffolding breaks down. This leads to a group of rare conditions called myofibrillar myopathies, where muscle fibers disintegrate and clump together, causing weakness and, in some cases, affecting the heart.
For years, doctors have struggled to understand the full picture of what happens when this specific protein fails. Because these conditions are rare, most medical knowledge came from studying small groups of families who happened to share the same genetic error. This made it difficult to see the whole range of how the disease behaves, from the muscles it weakens to the other organs it might harm. A team of researchers across France decided to change this by bringing together a much larger group of patients. They gathered medical records from twenty-seven individuals belonging to twenty-one different families. These patients had been confirmed to have a genetic error in the FLNC gene, and the team wanted to map out exactly how this specific error manifests in the real world.
The researchers found that the disease usually begins in adulthood, with the average person noticing symptoms around the age of forty. The most common sign was weakness in the muscles closest to the center of the body, such as the hips and shoulders, rather than the hands or feet. However, the pattern was not the same for everyone. About half of the patients had weakness only in these central muscles, while others experienced weakness in their limbs or a mix of both. A few patients had no muscle weakness in their arms or legs at all, presenting only with heart issues. This variety showed that the disease is far more flexible in how it appears than previously thought, defying a single, simple description.
Beyond the muscles, the heart was a major area of concern. Nearly half of the patients in the study had some form of heart involvement, ranging from the heart muscle becoming thick and stiff to becoming weak and enlarged. Some patients developed dangerous irregular heartbeats that required the implantation of a device to shock the heart back into a normal rhythm. This confirmed that for anyone diagnosed with this muscle condition, checking the heart is not optional; it is a critical part of managing the disease. Conversely, the study also noted that breathing problems were less common than in some other similar muscle diseases, though a small number of patients did require assistance with breathing at night.
To understand how the disease progresses, the team looked at the patients' muscles using magnetic resonance imaging, a type of scan that can see inside the body without cutting it open. They discovered a very specific pattern: the muscles in the back of the thighs were almost always the first to show signs of damage, appearing fatty and weak on the scans. Interestingly, a specific muscle in the inner thigh, the gracilis, remained healthy in every single case, acting as a reliable landmark for doctors to distinguish this condition from others. This consistent pattern on the scan provides a powerful tool for diagnosis, allowing doctors to spot the disease even before a muscle biopsy is needed.
When the researchers examined tissue samples taken from the patients' muscles under a microscope, they saw the physical evidence of the broken scaffolding. The muscle fibers were of uneven sizes, and many contained strange clumps of protein that should not be there. These clumps, which look like dark spots or rings inside the cells, are the result of the muscle trying to clean up the mess caused by the faulty protein but failing to do so. In a few rare cases, the researchers found a unique pattern of rod-shaped structures inside the muscle cells, a feature that had not been widely associated with this specific genetic error before. This discovery suggests that the disease can look different under the microscope depending on the specific type of genetic mistake a person carries.
Despite gathering a large number of patients, the team could not find a simple rule linking the specific type of genetic error to the specific symptoms a patient would have. One might expect that a certain kind of mistake in the gene would always lead to heart problems, while another kind would only affect the legs. However, the study showed that this was not the case. Patients with the same genetic error could have very different symptoms, and patients with different errors could have similar problems. This lack of a clear pattern means that doctors cannot yet predict exactly how a patient will fare based on their DNA alone.
The study concludes that this condition is a complex, adult-onset disease that primarily weakens the muscles of the trunk and limbs but frequently involves the heart. While the genetic cause is the same, the way it plays out in the body is highly variable. The researchers emphasize that because the disease can hide in the heart even when muscles seem fine, and because it can spare certain muscles while attacking others, a careful, multi-organ approach is needed for diagnosis and care. By documenting these twenty-seven patients, the team has provided a clearer, more complete map of the disease, helping to guide future doctors in recognizing and managing this challenging condition.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.